291 related articles for article (PubMed ID: 33372981)
21. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line.
El-Remessy AB; Rajesh M; Mukhopadhyay P; Horváth B; Patel V; Al-Gayyar MM; Pillai BA; Pacher P
Diabetologia; 2011 Jun; 54(6):1567-78. PubMed ID: 21373835
[TBL] [Abstract][Full Text] [Related]
23. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
24. Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.
Wang Q; Pfister F; Dorn-Beineke A; vom Hagen F; Lin J; Feng Y; Hammes HP
Diabetologia; 2010 Jun; 53(6):1227-38. PubMed ID: 20339831
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulphide mitigates homocysteine-induced apoptosis and matrix remodelling in mesangial cells through Akt/FOXO1 signalling cascade.
Majumder S; Ren L; Pushpakumar S; Sen U
Cell Signal; 2019 Sep; 61():66-77. PubMed ID: 31085234
[TBL] [Abstract][Full Text] [Related]
26. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Xu S; Liu Z; Liu P
Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
[TBL] [Abstract][Full Text] [Related]
27. Divergent effect of fast- and slow-releasing H
Pintus E; Jovičić M; Kadlec M; Ros-Santaella JL
Sci Rep; 2020 Apr; 10(1):6508. PubMed ID: 32300246
[TBL] [Abstract][Full Text] [Related]
28. The antihypertension effect of hydrogen sulfide (H
Zhu ML; Zhao FR; Zhu TT; Wang QQ; Wu ZQ; Song P; Xu J; Wan GR; Yin YL; Li P
Life Sci; 2021 Feb; 267():118831. PubMed ID: 33253721
[TBL] [Abstract][Full Text] [Related]
29. Endogenous H
Wang C; Du J; Du S; Liu Y; Li D; Zhu X; Ni X
Mol Cell Endocrinol; 2018 Oct; 474():65-73. PubMed ID: 29486221
[TBL] [Abstract][Full Text] [Related]
30. H
Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
[TBL] [Abstract][Full Text] [Related]
31. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
[TBL] [Abstract][Full Text] [Related]
32. Functional Regulation of an Oxidative Stress Mediator, Rac1, in Diabetic Retinopathy.
Mohammad G; Duraisamy AJ; Kowluru A; Kowluru RA
Mol Neurobiol; 2019 Dec; 56(12):8643-8655. PubMed ID: 31300985
[TBL] [Abstract][Full Text] [Related]
33. Exogenous H2S Protects Against Diabetic Cardiomyopathy by Activating Autophagy via the AMPK/mTOR Pathway.
Yang F; Zhang L; Gao Z; Sun X; Yu M; Dong S; Wu J; Zhao Y; Xu C; Zhang W; Lu F
Cell Physiol Biochem; 2017; 43(3):1168-1187. PubMed ID: 28977784
[TBL] [Abstract][Full Text] [Related]
34. Adaptor Protein p66Shc: A Link Between Cytosolic and Mitochondrial Dysfunction in the Development of Diabetic Retinopathy.
Mishra M; Duraisamy AJ; Bhattacharjee S; Kowluru RA
Antioxid Redox Signal; 2019 May; 30(13):1621-1634. PubMed ID: 30105917
[TBL] [Abstract][Full Text] [Related]
35. Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy.
Kowluru RA; Shan Y; Mishra M
Lab Invest; 2016 Oct; 96(10):1040-9. PubMed ID: 27454437
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA; Menon B; Gierhart DL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[TBL] [Abstract][Full Text] [Related]
37. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
38. H2S Attenuates LPS-Induced Acute Lung Injury by Reducing Oxidative/Nitrative Stress and Inflammation.
Zhang HX; Liu SJ; Tang XL; Duan GL; Ni X; Zhu XY; Liu YJ; Wang CN
Cell Physiol Biochem; 2016; 40(6):1603-1612. PubMed ID: 28006762
[TBL] [Abstract][Full Text] [Related]
39. Montelukast Prevents Early Diabetic Retinopathy in Mice.
Bapputty R; Talahalli R; Zarini S; Samuels I; Murphy R; Gubitosi-Klug R
Diabetes; 2019 Oct; 68(10):2004-2015. PubMed ID: 31350303
[TBL] [Abstract][Full Text] [Related]
40. A compensatory mechanism protects retinal mitochondria from initial insult in diabetic retinopathy.
Santos JM; Tewari S; Kowluru RA
Free Radic Biol Med; 2012 Nov; 53(9):1729-37. PubMed ID: 22982046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
